Ro 63-0563
Ro 63-0563 is a chemical compound that has been studied for its potential use as a pharmaceutical drug. It is primarily known for its role as a selective antagonist of the 5-HT6 receptor, a subtype of the serotonin receptor family. This receptor is predominantly found in the central nervous system and is implicated in various neurological processes, including cognition and mood regulation.
Pharmacology[edit | edit source]
Ro 63-0563 acts as a selective antagonist at the 5-HT6 receptor. By blocking this receptor, Ro 63-0563 can modulate the release of various neurotransmitters such as acetylcholine, dopamine, and glutamate, which are involved in cognitive processes. This has led to interest in Ro 63-0563 as a potential treatment for cognitive disorders such as Alzheimer's disease and schizophrenia.
Mechanism of Action[edit | edit source]
The 5-HT6 receptor is a G-protein coupled receptor (GPCR) that is positively coupled to adenylate cyclase. Antagonism of this receptor by Ro 63-0563 results in decreased cyclic AMP (cAMP) levels, which in turn affects downstream signaling pathways involved in neurotransmitter release and synaptic plasticity.
Research and Development[edit | edit source]
Ro 63-0563 has been the subject of various preclinical studies. Animal models have shown that Ro 63-0563 can improve performance in tasks that require learning and memory, suggesting its potential utility in treating cognitive impairments. However, as of the latest updates, Ro 63-0563 remains an investigational compound and has not been approved for clinical use.
Potential Applications[edit | edit source]
Due to its effects on cognitive function, Ro 63-0563 is being explored for its potential in treating:
Safety and Efficacy[edit | edit source]
The safety profile of Ro 63-0563 is still under investigation. Preclinical studies have not reported significant adverse effects, but comprehensive clinical trials are necessary to establish its safety and efficacy in humans.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
